Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XTLB XTL Biopharmaceuticals Ltd. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.13 -7.4% | $15.90 -2.5% |
| StockIQ Score | 31F Weak Risk: High | 41D Weak Risk: High |
| Technical | 23F | 36F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
XTLB shows a weaker investor confidence with a score of 31 compared to AAPG’s 41. While both carry a "WEAK" rating, AAPG stands out with higher technical (36 vs. 23), fundamental (35), growth (50), and valuation (38) scores, indicating stronger overall metrics. AAPG appears more balanced across key categories.
